United States News All stories

iHeartMedia (NASDAQ:IHRT) and Netflix (NASDAQ:NFLX) announced an expansion of their exclusive video podcast agreement to include new shows from prominent creators such as Kate Hudson, Oliver Hudson, Lele Pons, and Martha Stewart.

Neurocrine Biosciences (NASDAQ:NBIX) presented two-year pediatric data for its CRENESSITY therapy at the ENDO 2026 medical conference.

enGene Therapeutics (NASDAQ:ENGN) announced its financial results for the second quarter ended April 30, 2026, alongside updates on its clinical development pipeline.

Elicio Therapeutics (NASDAQ:ELTX) announced results from its randomized Phase 2 AMPLIFY-7P trial evaluating ELI-002 7P in patients with mKRAS-driven pancreatic ductal adenocarcinoma.

Precigen (NASDAQ:PGEN) has been granted FDA orphan drug exclusivity for its product PAPZIMEOS, used to treat adult recurrent respiratory papillomatosis.

Salesforce (NYSE:CRM) announced it will acquire Fin, formerly known as Intercom, for approximately $3.6 billion to accelerate its position in the autonomous agent market.

Humacyte (NASDAQ:HUMA) announced that its Phase 3 V012 study met its primary superiority endpoint, showing the company’s acellular tissue engineered vessel (ATEV) significantly reduces time spent on dialysis catheters.

TuHURA Biosciences (NASDAQ:HURA) announced today that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to advance its TBS-2025 therapy.

Paranovus Entertainment Technology (NASDAQ:PAVS) executed a non-binding letter of intent to acquire Jabanero for a proposed all-cash purchase price of $15 million to $20 million.

Jerash Holdings (NASDAQ:JRSH) reported record full-year fiscal 2026 revenue of $166.3 million following a 46.6% surge in fourth-quarter sales.

Alkermes plc (NASDAQ:ALKS) announced that its investigational oral medication, alixorexton, was granted orphan drug designations by regulatory authorities in the United States and Europe for rare sleep disorders.

IREN (NASDAQ:IREN), a leading vertically integrated AI Cloud infrastructure provider, today announced the formal completion of its acquisition of Ingenostrum, S.L., widely known as Nostrum Group.

Coda Octopus Group (NASDAQ:CODA) reported its fiscal second-quarter 2026 financial results for the period ended April 30, 2026.

Tripadvisor (NASDAQ:TRIP) executed a put option agreement to sell its European online restaurant reservation and management platform, TheFork, to American Express (NYSE:AXP) for $700 million in cash.

Generac Holdings (NYSE:GNRC) has finalized the acquisition of a new manufacturing facility in Belvidere, Illinois.

Honeywell (NASDAQ:HON) has greenlit a structural corporate split, separating its high-performing aerospace operations from its automation and software assets.

Canopy Growth (TSX:WEED) (NASDAQ:CGC) delivered a mixed but structurally stronger fiscal 2026 financial report, showcasing accelerating top-line momentum in its core cannabis business alongside major balance sheet repair.

Context Therapeutics (NASDAQ:CNTX) revealed encouraging preliminary clinical data from its Phase 1a trial evaluating CTIM-76, an investigational bispecific T cell engager designed to target claudin 6 (CLDN6) and engage CD3 T cells.

Parsons (NYSE:PSN) has secured a sole-source, indefinite-delivery/indefinite-quantity (IDIQ) contract from the U.S. Navy worth up to $184 million to support the Intelligence Carry-On Program (ICOP).

Diana Shipping (NYSE:DSX), the largest shareholder of Genco Shipping & Trading (NYSE:GNK), launched a direct offensive against Genco's board of directors, accusing them of corporate entrenchment and attempting to manipulate shareholder democracy.

Johnson & Johnson (NYSE:JNJ) has committed more than $1 billion to expand and modernize its Vision care operations in Jacksonville, Florida, targeting increased capacity for its market-leading ACUVUE®-brand contact lenses.

Comtech Telecommunications (NASDAQ:CMTL) executed a definitive agreement to divest the majority of its Satellite and Space Communications segment to Gilat Satellite Networks (NASDAQ:GILT) for $137.5 million in cash and secondary asset retentions, modifying its core operating structure.

High Tide (NASDAQ:HITI) executed a definitive agreement to acquire 100 percent of J. Supply Holdings to add four active Northern Helm retail cannabis stores located across Ontario.

IDEAYA Biosciences (NASDAQ:IDYA) enrolled the first patient in its Phase 1/2 clinical trial evaluating the combination of its drug candidates, IDE892 and IDE397, in patients with MTAP-deleted solid tumors.